Colitis, Ulcerative, drug therapy

All categories
Name
Colitis, Ulcerative, drug therapy
Accession Number
DBCAT001743
Description

Not Available

Drugs
DrugDrug Description
AndrographolideInvestigated for use/treatment in ulcerative colitis.
IzencitinibIzencitinib is under investigation in clinical trial NCT03920254 (TD-1473 Long-term Safety (LTS) Ulcerative Colitis (UC) Study).
Drugs & Drug Targets
DrugTargetType
AndrographolideTumor necrosis factortarget
AndrographolideInterleukin-1 betatarget
AndrographolideInterleukin-6target
AndrographolideNuclear factor NF-kappa-B p100 subunittarget
AndrographolideNuclear factor NF-kappa-B p105 subunittarget